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ABSTRACT
Translation of the sigma factor RpoS is activated by
DsrA, RprA and ArcA, three small non-coding sRNAs
(sRNA) that expose the ribosome-binding site (RBS)
by opening up an inhibitory loop. In the RpoS
network, no sRNAs have been found to pair with
the RBS, a most common sRNA target site in
bacteria. Here, we generate Ribo-0, an artificial
sRNA, which represses rpoS translation by pairing
with the RBS. Ribo-0 bypasses the RNA chaperon
Hfq but requires the RBS to be loosely blocked.
Ribo-0 interacts with DsrA and reshapes the RpoS
network. Specifically, in the intact RpoS network,
DsrA activates rpoS translation by freeing up the
RBS. In the modified RpoS network where Ribo-0
is introduced, the DsrA-caused RBS exposure facili-
tates Ribo-0 binding, thereby strengthening Ribo-0
inhibition. In other words, Ribo-0 changes DsrA from
an activator to an accomplice for repressing rpoS
translation. This work presents an artificial mechan-
ism of rpoS regulation, reveals mutual effects of
native and synthetic players and demonstrates
genetic context-dependency of their functions.
INTRODUCTION
The alternative sigma factor RpoS is a key master regula-
tor of stress response (1–5), governing expression of >200
genes in Escherichia coli (6,7). The rpoS gene has a long
messenger RNA (mRNA) leader with complex structure
carrying a cis-acting antisense element that blocks
ribosome access and consequently reduces rpoS transla-
tion. In addition, the rpoS leader interacts with multiple
small non-coding RNAs (sRNA) that modulate rpoS
mRNA stability and translation. Thus, the rpoS mRNA
provides a natural platform for characterization of cis-
and trans-regulation of gene expression as well as their
interplay.
rpoS translation is activated by sRNAs DsrA (8,9),
RprA (10,11) and ArcZ (12), and it inhibited by OxyS
(13). All the positive sRNA regulators interact with the
cis-acting antisense element in the distal region of the rpoS
leader, freeing up the ribosome-binding site (RBS) and
derepressing rpoS translation. In contrast, there is no
evidence for the direct interaction of OxyS with rpoS,
and the regulatory mechanism of OxyS remains unclear
(13).
Many sRNAs exert their inhibitory regulation by
pairing with RBS of their target mRNAs. However, this
action seems to be absent from the RpoS network or yet to
be identiﬁed. Therefore, it is of interest to introduce an
artiﬁcial sRNA inhibitor that directly binds to the rpoS
RBS and to see whether and how the alien player interacts
with the native regulators and alters the genetic network.
The ﬁndings would provide new insight into how the rpoS
network works and shed light on network design. Recent
advance in synthetic biology makes this task possible. By
combining rational design and random library screening,
we have generated an artiﬁcial sRNA-designated Ribo-0
that speciﬁcally pairs with the RBS. We show that Ribo-0
signiﬁcantly reduces rpoS expression and bacterial acid
resistance. Interestingly, the alien sRNA alters perform-
ance of native players in the rpoS network. Speciﬁcally,
Ribo-0 reverses the function of the endogenous sRNA
DsrA, changing it from an activator of rpoS translation
to an inhibitor that enhances the Ribo-0 repression. This is
because binding of DsrA to the distal region of rpoS
exposes the RBS and facilitates Ribo-0 pairing with this
site. Thus, the role of DsrA is both positive and negative
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depending on the genetic context it resides in. These
studies show how an artiﬁcial sRNA can be designed to
regulate rpoS and reshape the natural genetic network by
interacting with other players. Similar strategies may be
extrapolated to other genetic networks or used for
network design.
MATERIALS AND METHODS
Escherichia coli strains and growth conditions
The bacterial strains and plasmids used in this study are
listed in Supplementary Table S1. The E. coli strain
MG1655 was used for phenotypic examination through-
out this study. All MG1655 mutants were grown at 37C,
with shaking at 220 rpm, in Luria-Bertani (LB) medium.
The E. coli DY330 strain was used for plasmid prepar-
ation and grown at 32C in LB medium. The antibiotics
ampicillin (50mg/ml), kanamycin (50 mg/ml) and chloram-
phenicol (12.5 mg/ml) were used for selection when
appropriate.
DNA manipulations and sRNA library construction
Gene deletion was performed using the recombineering
system (14,15). Escherichia coli MG1655 was transformed
with plasmid pSim6 (a gift from Dr Donald Court) from
which the expression of the  recombination proteins is
induced at 42C. PCR fragments encompassing a loxP-
cat-loxP with homology (45 nt) to the regions immediately
ﬂanking each deletion locus were transformed via
electroporation into MG1655 cells harboring pSim6.
After induction of red functions, recombinants were
selected for chloramphenicol resistance (encoded by the
cat gene) and were further veriﬁed by colony PCR and
sequencing.
For construction of an sRNA Ribo-0 library, the loxP-
cat-loxP fragment was ﬁrst linked to a constitutive
promoter, which was used to drive sRNA expression, by
overlapping PCR. The resulting PCR product was then
precisely ligated to a 6-nt random sequence followed by
a base pairing domain and a 6-uracil (U) string by
overlapping PCR. The ﬁnal PCR products with
homology (45 nt) to the insertion site of a pET expression
vector was transformed together with the vector into the
DY330 strain after induction of red. Recombinants were
selected for chloramphenicol resistance and then collected
for plasmid isolation.
rpoS-lacZ translational fusion and beta-galactosidase
assays
The rpoS-lacZ translational fusion on the chromosome of
E. coliMG1655 was constructed previously (16). Brieﬂy, a
lacZ-chloramphenicol resistance (cat) cassette starting
with the eight codon of lacZ was linked by recombineering
to the second last codon of rpoS. Cells carrying the rpoS-
lacZ fusion were incubated overnight (at stationary phase)
in LB medium at 37C before quantiﬁcation of the fusion
expression. Expression of the rpoS-lacZ fusion was
quantiﬁed using a beta-galactosidase assay as described
previously (16,17). Levels of beta-galactosidase were
calculated using the following formula:
units Uð Þ ¼OD420 1000=ðOD600
 hydrolysis time volume of lysateÞ
Acid resistance assay
Overnight cultures were treated with acid (pH 2.0) for 2 h
and then serially diluted in neutral medium. For cells
deleted for rpoS, which are highly sensitive to acidic
stress, they were treated with acid for 15min. Colony
forming units (CFU) were determined immediately
before and after the acid treatment. Acid survival (%)
was calculated with the following formula:
Acid survival ð%Þ ¼ 100 ðpost-treatment
CFU=pre-treatment CFUÞ
RNA isolation, ribonuclease protection assay and
real-time PCR
Total RNAs were isolated using Trizol agent (Invitrogen)
and then treated with TURBO DNaseI (Ambion, Austin,
TX) to remove any DNA residuals. For determination of
RNA decay, RNAs were isolated 0, 10, 20 and 30min
after rifampicin (ﬁnal concentration=500 mg/ml) was
added to each culture. Ribonuclease protection assay
(RPA) was performed using a RPA III kit (Ambion,
Austin, TX). Speciﬁcally, biotin-labeled probes were
synthesized in vitro using Biotin-14-CTP and the
MAXIscript Kit from Ambion (Austin, TX), gel puriﬁed
and quantiﬁed by UV spectrophotometry. Ten micro-
grams of total RNA and 500 pg of each biotin-labeled
probe were mixed, coprecipitated and hybridized over-
night at 42C. The RNAs were then digested with
RNaseA/RNase T1 mixture and run on a denaturing
polyacrylamide gel (5%) in TBE buffer. The protected
RNAs were transferred to a positively charged nylon
membrane and visualized using the BrightStar
BiotinDetect Kit (Ambion, Austin, TX).
For real-time PCR, 2 mg of total RNA was reverse
transcribed in a total reaction volume of 20 ml. Each
reaction was incubated at 55C for 50min, followed by
15min at 70C. The resulting reverse transcript products
(complementary DNA) were then used for real-time PCR,
which was carried out using an LightCycler
480II Detection System (Roche Diagnostics, Rotkreuz,
Switzerland) and primers complementary to rpoS
(rpoS-F, 50-TCGCCGCCGGATGATCGAGA-30; rpoS-
R, 50-CGCGGATCAGCCCCAGGTT-30) and the
16 S rRNA gene (16S-F, 50-CCCTTGAGGCGTGGCTT
CC-30; 16S-R, 50-GCGGGCCCCCGTCAATTCAT-30).
Reactions were run in triplicate in three independent ex-
periments. The 16S rRNA gene was used as an internal
control. Expression data were normalized to that of wild-
type cells carrying an empty vector pCm.
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Statistical analysis
Paired t-tests were used to compare two means, and one-
way ANOVA tests were used to compare multiple means
obtained from beta-galactosidase, acid resistance assays
and real-time PCR. P-values of <0.05 were considered
statistically signiﬁcant.
RESULTS
Establishment of a random library to screen for synthetic
sRNAs that inhibit rpoS expression
We combined rational design and random library
screening to create an artiﬁcial sRNA that represses
rpoS expression. The sRNA was designed to carry two
stem-loop structures at the 50 end, a 6-nt random
sequence, a base-pairing domain (containing 18 nt), a 6-
U stretch followed by a T7 transcriptional terminator
(Figure 1A). The stem loops at the 50 end make the
sRNA highly structured and are therefore intended to
enhance sRNA stability. The base-pairing domain is
complementary to the RBS and intended to silence rpoS
translation. The T7 terminator serves to halt sRNA tran-
scription. The 6-U stretch has the potential to serve as an
Hfq-binding site for the artiﬁcial sRNA, as the RNA
chaperon Hfq binds preferentially to A/U-rich sequences
(18–21). However, these modules do not guarantee gener-
ation of a functional sRNA, as regulatory mechanisms of
sRNAs are not fully understood. We therefore introduced
the aforementioned random sequence to establish a sRNA
library, from which functionally active sRNAs could be
screened for.
We synthesized a double-stranded DNA fragment
composed of all the aforementioned modules by PCR.
The resulting DNA fragments containing the 6-nt
random sequence were then cloned into a multi-copy
vector (a pET vector deleted for the T7 promoter) under
the control of a constitutive promoter of the csrB gene
encoding the natural sRNA CsrB, generating a sRNA
random library. The sRNA library was then introduced
into a previously constructed chromosomal rpoS-lacZ
translational fusion strain (the last second codon of rpoS
fused with the eight codon of lacZ) (22), giving rise to a
mixed population of cells harboring 1 46 putative
sRNAs. Single colonies formed on X-gal agar plates
after overnight culture, each overproducing a putative
sRNA that has the potential to repress rpoS through the
designed base-pairing domain (Figure 1B).
An artiﬁcial sRNA named Ribo-0 signiﬁcantly inhibits
rpoS expression
Approximately 5000 colonies were screened by color. The
majority of the clones were blue, indicating that most
sRNA candidates have no regulatory effects on the
rpoS-lacZ fusion expression despite the rational design.
This shows the necessity of introducing a random region
to ensure creation of functionally active sRNAs, as we did
in this study. Only two clones appeared to be whiter than
others and potentially carried sRNA inhibitors of rpoS.
Plasmids were isolated from the whiter clones, and
sequencing analysis revealed that they carried the same
sRNA construct, in which the 6-nt random sequence
was UAUUAU (Figure 2A). The identiﬁed sRNA was
hereafter referred to as Ribo-0. The random sequence
starts with UAUU, which is complementary with the
ﬁrst 4 nt of the rpoS coding region. Thus, Ribo-0 is
likely to interfere not only with the accessibility of the
RBS but also with translational initiation. As negative
controls, two blue colonies were randomly selected and
their sRNAs were designated Ribo-1 and Ribo-2.
Sequencing of Ribo-1 and Ribo-2 revealed that their
sequence in the random region was CCGAAA
(Figure 2B) and AUGCAG (Figure 2C), respectively.
Secondary minimum free energy structures of Ribo-
0, Ribo-1 and Ribo-2 were predicted by using the
program RNAstructure5.1 (http://rna.urmc.rochester.
edu/RNAstructure.html) (23). Ribo-0, Ribo-1 and Ribo-
2 fold into multiple stem loops and, therefore, are all
highly structured (Figure 2A–C).
To examine the putative Ribo-0 regulation of rpoS ex-
pression, we transformed the rpoS-lacZ fusion strain with
the plasmid carrying Ribo-0 or the negative controls
(including pRibo-1, pRibo-2 and an empty control
vector pCm) and then measured beta-galactosidase
activity of the resulting transformants. Compared with
the negative control pCm, Ribo-0 overproduction
reduced the rpoS fusion expression by 93% (Figure 2D).
In contrast, neither Ribo-1 nor Ribo-2 signiﬁcantly
affected the rpoS fusion expression (Figure 2D). Ribo-1
Figure 1. Strategy for construction of a random sRNA library.
(A) Design of a library of artiﬁcial sRNAs that repress rpoS translation
by pairing with the RBS. Each putative sRNA was composed of two
stem loops at the 50 end, a 6-nt random sequence (shown in red), a
base-pairing domain (shown in green), a poly-U stretch and a T7 ter-
minator. The 6-nt random sequence allows for establishment of a
library containing 46 putative sRNAs. The base-pairing domain is com-
plementary to the RBS of the rpoS mRNA. To facilitate screening for
active sRNAs, rpoS was fused in frame with lacZ. (B) Screening
strategy used to search for artiﬁcial sRNAs that signiﬁcantly inhibit
expression of the rpoS-lacZ fusion, generating whiter colonies on LB
agar plus X-gal. The chosen clones were then veriﬁed by PCR and
sequencing.
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and Ribo-2 may be unable to repress rpoS owing to their
inactive structures or poor stability as a result of their
different random sequence from that of Ribo-0. We did
not dig into the underlying reason, as this is not what we
set out to address. The aim of this study is to explore how
artiﬁcial sRNAs like Ribo-0 reshape the RpoS regulatory
network, as mentioned in the introduction section.
It is well established that RpoS is required for resistance
of E. coli to extreme acidic stress (1). Consistent with this,
E. coli MG1655 overproducing Ribo-0 were signiﬁcantly
more acid sensitive than those carrying Ribo-1, Ribo-2 or
pCm (Figure 2E, note different scale for this ﬁgure),
conﬁrming the Ribo-0 repression of rpoS. Ribo-0 did not
affect acid resistance in an rpoS null mutant, indicating
that rpoS is the only target for Ribo-0 to regulate acid re-
sistance (Supplementary Figure S1A). We then used quan-
titative real-time PCR to examine the effects of Ribo-0 on
levels of rpoS transcript. Ribo-0 did not signiﬁcantly
reduce rpoS transcription compared with the negative
controls (Figure 2F), verifying that Ribo-0 represses rpoS
expression primarily at the translational level as designed.
Ribo-0 directly interacts with rpoS mRNA
Next, we sought out to verify that Ribo-0 operates by
acting on the RBS and the neighboring regions of rpoS.
We inserted a cat cassette in sites with increasing distance
from the translational start site. Regions upstream of the
insertion sites were replaced by the cassette, resulting in 50
leaders with different lengths (Figure 3A). The cat cassette
contained a constitutive promoter so that rpoS could still
be transcribed in the absence of its native promoters. The
resulting mutants were named D0, D21 and D115, as 0, 21
and 115 nt of the rpoS leader upstream of the translational
start site were left intact, respectively. For construction of
D0, the RBS of rpoS was replaced by the RBS of the lacI
gene. With D115, Ribo-0 retained the inhibitory effects on
the rpoS-lacZ expression and acid resistance (Figure 3B).
This was also true for D21 where the mRNA leader con-
tained the native RBS but otherwise completely differed
from the wild-type rpoS leader (Figure 3B), suggesting
that the 50 UTR regions upstream of the RBS is not es-
sential for the Ribo-0 regulation of rpoS. In contrast, with
D0 where the entire rpoS leader was moved and the rpoS
RBS was replaced by the lacI RBS, Ribo-0 lost the regu-
lation of the rpoS-lacZ expression and acid resistance,
suggesting that the rpoS RBS is the target site of Ribo-0.
To provide more evidence for the direct interaction of
Ribo-0 with rpoS, we carried out compensatory mutation
experiments. First, we mutated the designed binding site in
the rpoS mRNA to see whether the mutations abolished
Figure 2. Repression of rpoS expression by the artiﬁcial sRNA Ribo-0. (A) Predicted secondary structures and veriﬁed sequences of Ribo-0,
(B) Ribo-1 and (C) Ribo-2. The color scheme used: the 6-nt random sequence, red; the base-pairing domain, green. (D) Regulation of chromosomal
rpoS-lacZ fusion by Ribo-0, Ribo-1 and Ribo-2. The rpoS fusion expression was determined using beta-galactosidase assays. (E) Regulation of acid
resistance by Ribo-0, Ribo-1 and Ribo-2. Survival percentages after 2 h of acid treatment (pH 2.0) were determined by counting CFUs. (F) Effects of
Ribo-0, Ribo-1 and Ribo-2 on rpoS mRNA levels. rpoS transcripts were quantiﬁed using real-time PCR. The 16S RNA was used as an internal
control to ensure comparability of the samples. In experiments shown in Figures (D), (E) and (F), cells carrying pCm (an empty control) served as a
negative control in addition to those overproducing Ribo-1 and Ribo-2. Error bars represent standard deviation (*P< 0.05).
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the Ribo-0 repression. The RBS consensus sequence and
the start codon were not mutated to maintain proper rpoS
expression. Instead, 6 nt upstream of the RBS were
changed from CACGGG to GUGCCC to disrupt the ex-
tensive complementarities between Ribo-0 and the rpoS
mRNA. We introduced the mutations both to the rpoS-
lacZ fusion and to the wild-type strain, generating
mutants named LComp and Comp, respectively. The mu-
tations impaired the regulation of the rpoS fusion expres-
sion and acid resistance by Ribo-0 (Figure 3C). We then
introduced compensatory mutations to Ribo-0 so that the
resulting sRNA named Ribo-c perfectly paired with the
RBS and the neighboring regions of the mutated rpoS. As
shown in Figure 3C, Ribo-c did not affect the unmutated
rpoS but restored the regulation of the mutated rpoS.
Taken together, these results clearly demonstrate that
Ribo-0 directly interacts with the rpoS mRNA via the
designed binding site.
Ribo-0 bypasses the requirement for Hfq
The random sequence in Ribo-0 was A/U rich (UAUUA
U). It is tempting to speculate that the A/U-rich fragment
may be an Hfq-binding site, as Hfq binds preferentially to
single-stranded regions rich in A/U (18–21). If Hfq is
required for the rpoS regulation by Ribo-0, then Ribo-0
should be unable to regulate rpoS expression in the
absence of the RNA chaperon protein. However, beta-
galactosidase and acid resistance assays showed that
Ribo-0 retained the inhibition of rpoS expression in an
hfq null mutant (Figure 4A). Many native sRNAs have
longer half-lives (10–30min) as a result of interaction with
Hfq (24,25). This led us to determine whether the decay
rate of Ribo-0 is affected by Hfq. No difference in the
Ribo-0 stability was found between the wild-type strain
and the hfq null mutant as revealed by the nuclease pro-
tection analysis of the rifampicin-treated cultures
(Figure 4B). It has been previously reported that the
rpoS leader contains two Hfq-binding sites [an A6 and
an (AAN)4 element] (26,27). If Ribo-0 bypasses Hfq,
then removing the Hfq-binding sites from the rpoS
leader would not affect the repression of rpoS by Ribo-
0. In accordance with this, Ribo-0 retained the rpoS regu-
lation in D115 and D21 from which the Hfq-binding sites
were absent (Figure 3B). These observations collectively
suggest that Ribo-0 is functional without the need for Hfq.
It has previously been demonstrated that Hfq is not essen-
tial for sRNAs when they tightly pairs with their mRNA
targets (26,28). Thus, the independence of Ribo-0 on Hfq
suggests that Ribo-0 and rpoS form a stable complex on
their own.
Ribo-0 requires a loosely blocked RBS
In the rpoS leader, the RBS is loosely blocked by a cis-
acting antisense element. If this inhibitory element
Figure 3. Direct interaction between Ribo-0 and rpoS. (A) Structure of the rpoS leader and design of its truncation. The green line denotes the cis-
acting antisense element that pairs with the RBS region. The red line denotes Hfq-binding sites. The arrows indicate where truncation was made in
the rpoS leader. The numbers indicate the nucleotide at the 50 end of the rpoS leader, relative to the translational start site. In mutants D115, D21
and D0, 115 nt, 21 nt and 0 nt of the rpoS leader immediately upstream of the translational start site were left intact, respectively. In D0, the rpoS
RBS was replaced by the lacI RBS (shown in yellow). (B) Regulation of the rpoS-lacZ translational fusion and acid resistance by Ribo-0 in various
strains. Cells carrying pCm (an empty control) served as a negative control. Error bars represent standard deviation (*P< 0.05). (C) Effects of
compensatory mutations. Mutations (in red) made upstream of the RBS (in blue) in the rpoS leader (resulting in a mutant referred to as Comp or
LComp in the rpoS-lacZ fusion background) and compensatory mutations (in green) made in Ribo-0 (resulting in a Ribo-0 variant referred to as
Ribo-c) were highlighted in red. Error bars represent standard deviation (*P< 0.05).
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perfectly pairs with the RBS, the gene expression would be
silenced, leaving no room for Ribo-0 to further repress the
expression. To test this hypothesis, we sought out to con-
struct an artiﬁcial cis-acting antisense element that binds
to the RBS more tightly than the native one. We took
advantage of a native element in the rpoS leader that is
perfectly complementary to the RBS region. This base-
pairing element is unlikely to bind to the RBS in the
wild-type rpoS leader, as previous evidence did not
reveal such a structure. We therefore did more serial de-
letions in the rpoS leader to search for a construct in which
this otherwise inert element forms an inhibitory loop with
the RBS region. We found that a mutant named D87, in
which 87 nucleotides upstream of the translational start
site was left intact (Figure 5A), showed 25% of the wild-
type rpoS expression and 0.03% of the wild-type acid re-
sistance (Figure 5B). Prediction of secondary structure of
the D87 rpoS leader revealed that the 12-nt element
between 49 and 38 perfectly pairs with the RBS and
neighboring sequences (Figure 5C). Local free energy of
this perfectly base-paired structure and its native counter-
part is 14.2 kcal/mol and 10.5 kcal/mol, respectively.
Thus, the 12-nt element in D87 blocks the RBS of rpoS
more tightly than the antisense element in the wild-type
strain. In agreement with our hypothesis, when the RBS
perfectly paired with the cis-acting antisense element,
Ribo-0 failed to further reduce rpoS expression and acid
resistance (Figure 5D). We then introduced mutations to
the rpoS fusion and the wild-type strain to disrupt the
perfect base pairing. The resulting mutants were referred
to as LD87im and D87im, respectively. Ribo-0 restored
the repression of rpoS expression and acid resistance of the
mutants (Figure 5D). Together, the RBS of rpoS has to be
loosely blocked for the Ribo-0 modiﬁcation of the RpoS
network.
Interplay of Ribo-0 and native regulation of RpoS
It is well established that rpoS translation is repressed by
the cis-acting antisense element, which sequesters the RBS
and prevents ribosome docking. As described earlier in the
text, Ribo-0 represses rpoS translation by pairing with the
RBS. In contrast, the native sRNA DsrA is partially com-
plementary to the cis-repressive element, freeing up the
RBS and activating rpoS translation (29,30). We
speculated that the DsrA-caused exposure of the RBS
would facilitate Ribo-0 binding, thereby strengthening
silencing effects of Ribo-0. Conversely, Ribo-0 was
expected to change DsrA from an activator to an accom-
plice of Ribo-0 (Figure 6A). In agreement with our hy-
pothesis, Ribo-0 reduced the rpoS-lacZ fusion expression
by 45% in a dsrA mutant background, but the percentage
increased to 93% in the wild-type strain with chromo-
somal DsrA (Figure 6B). Consistently, Ribo-0 resulted
in a 10-fold reduction in survival percentage after 2 h
acid challenge in the absence of DsrA, but it led to a
200-fold reduction in acid resistance when DsrA was
present (Figure 6B). The beta-galactosidase and acid re-
sistance results demonstrate that Ribo-0 requires DsrA for
its optimal silencing effects on rpoS. Conversely, Ribo-0
altered the role of DsrA in rpoS regulation. In the absence
of Ribo-0, DsrA acted as an activator of rpoS expression.
In the presence of Ribo-0, however, DsrA turned into
reducing the rpoS-lacZ fusion expression and accordingly
acid resistance (Figure 6B). Thus, Ribo-0 reverses the
function of DsrA, transforming it into a repressor of
rpoS. The interplay of Ribo-0 and DsrA gives rise to a
new network that achieves stepwise regulation of rpoS.
That is, rpoS expression is ON in the presence of chromo-
somal DsrA; 50% of rpoS expression is inhibited when
DsrA is absent; this ﬁgure is increased to 72% when
Ribo-0 is overproduced and DsrA is absent; the optimal
silencing effects (93%) are achieved in the presence of
DsrA when Ribo-0 is overproduced (Figure 6A).
Chromosomal DsrA requires the Hfq chaperon to be
functional (31). We therefore speculated that the interplay
between Ribo-0 and DsrA would disappear in the D115
strain, as the Hfq-binding sites are absent from its rpoS
leader. In accordance with this, deleting the dsrA gene
Figure 4. Independence of Ribo-0 on the Hfq protein. (A) Ribo-0 retained regulation of the rpoS-lacZ translational fusion and acid resistance in an
hfq null mutant ( hfq). Error bars represent standard deviation (*P< 0.05). (B) Ribo-0 decay in the wild-type strain (wt) and  hfq. Rifampicin
(ﬁnal concentration: 500mg/ml) was added to cultures in the stationary phase to stop transcription. Aliquots of cells were taken at 0, 10, 20 and
30min after the addition of rifampicin. Total cell RNA was isolated at each time point, and RPA was performed to quantify sRNAs. The stable 16 S
RNA was used as an internal control.
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from the D115 background did not affect rpoS expression
or acid resistance and had no impact on the Ribo-0 regu-
lation (Supplementary Figure S1B). It has been previously
demonstrated that overexpressed sRNA OxyS competes
with some endogenous sRNAs for binding to Hfq,
thereby lowering their accumulation and regulatory
activity (32). This led us to ask whether Ribo-0 regulates
rpoS expression and interacts with DsrA by sequestering
Figure 5. Requirement of the Ribo-0 regulation of RpoS for the loosely folded inhibitory loop in the 50 leader. (A) Structure of the rpoS leader and
the location where D87 was constructed. The green line denotes the cis-acting antisense element that pairs with the RBS region. The red line denotes
Hfq-binding sites. The numbers indicate the nucleotide at the 50 end of the rpoS leader, relative to the translational start site. (B) Silenced expression
of the rpoS-lacZ fusion and low levels of acid resistance in the mutant D87. (C) Predicted secondary structures of the naturally occurring inhibitory
loop (upper panel) in the wild-type strain, a perfectly folded inhibitory loop in D87 (middle panel) and an artiﬁcial imperfect inhibitory loop in
D87im (lower panel). Mutations made in D87im are highlighted in red and the RBS is highlighted in blue. (D) Defect of Ribo-0 in regulation of the
rpoS fusion expression and acid resistance in D87, and restoration of the regulation in D87im.
Figure 6. Interplay of Ribo-0 and DsrA. (A) Model for stepwise regulation of rpoS by Ribo-0 and DsrA. Abbreviations in the upper panel: CR, cis-
acting repressive element in the rpoS leader; RBS, ribosome binding site. (B) Mutual effects of Ribo-0 and DsrA in their regulation of the rpoS fusion
expression and acid resistance. Error bars represent standard deviation (*P< 0.05).
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Hfq. If Ribo-0 repressed rpoS expression by competing
with DsrA for Hfq, then Ribo-0 overproducers with
chromosomal DsrA should produce more (or no less)
RpoS than those deﬁcient in DsrA. Our data, however,
showed the opposite (Figure 6B). This together with the
aforementioned ﬁnding that Ribo-0 functioned independ-
ently of Hfq suggests that the interplay between Ribo-0
and DsrA is not due to competition for Hfq.
DISCUSSION
Bacteria possess diverse means of gene regulation using
RNA regulators such as cis-acting antisense mRNA
leaders that sequester the RBS to prevent ribosome
docking (8,33), cis-acting riboswitches that sense and
respond to the availability of speciﬁc ligands, trans-
acting sRNA that pair with target RNAs or bind to
proteins and CRISPR RNAs that repress the uptake of
foreign DNA (34). Among these, the trans-acting sRNAs
are the largest set of RNA regulators, and hundreds of
naturally occurring sRNAs have been identiﬁed. Most of
them act through pairing with target mRNAs, modulating
their translation and stability. An sRNA can target
multiple mRNAs. For instance, Spot42 regulates at least
15 operons involved in uptake and catabolism of diverse
carbon sources (35). An mRNA can also be regulated by
multiple sRNAs. One example is rpoS that encodes the
alternative sigma factor RpoS implicated in stress resist-
ance (1–5) and virulence (36). rpoS translation is activated
by DsrA (8,9), RprA (10,11) and ArcZ (12) and repressed
by OxyS (13). Although the regulatory mechanisms of
DsrA, RprA and ArcA have been intensively investigated,
the OxyS inhibition of rpoS translation remains poorly
understood. It is now known that OxyS does not repress
rpoS translation by binding to the RBS region and that no
sRNA has been identiﬁed to interact with the RBS region
of rpoS. Here, we ﬁlled the gap by creating a trans-acting
sRNA Ribo-0 that inhibits rpoS translation by pairing
with the RBS region. The pre-designed action of Ribo-0
allows us to explore the implication of multiple sRNA
regulators for a single target (rpoS in this context) and
how they interact with each other by binding to different
domains of the mRNA leader.
Combining rational design and random library
screening, we have created an artiﬁcial sRNA named
Ribo-0 that was designed to inhibit rpoS translation.
Although all the sRNA candidates carried the base-
pairing domain as well as other pre-designed modules,
the majority of them had little regulatory functions. This
suggests that inclusion of these regulatory modules is
necessary but not sufﬁcient for creating a functionally
active sRNA owing to our incomplete understanding of
their regulatory mechanisms. This also demonstrates the
necessity of combining random library screening and
rational design for creation of gene-speciﬁc sRNAs.
Physiological, biochemical and genetic evidence has
been provided for the direct interaction between Ribo-0
and the rpoS gene. The only difference between Ribo-0
and thousands of inactive variants such as Ribo-1 and
Ribo-2 is that the latter do not pair with the translational
AUG start site of rpoS, suggesting that the Ribo-0
complementarity to the AUG start site is essential.
Furthermore, the compensatory mutation assays
revealed that complementarity to the region ﬂanking the
RBS is also indispensable. Collectively, the RBS and the
neighboring regions including the AUG start site is a
minimal base-pairing domain required for the Ribo-0
regulation of rpoS. Disruption of the complementarities
between Ribo-0 and any elements of this base-pairing
domain would impair the regulation of rpoS by Ribo-0.
The successful design and creation of the rpoS-speciﬁc
sRNA indicate that artiﬁcial sRNAs with user-deﬁned
performance can be used to manipulate cell biology in a
programmatic fashion. More interestingly, we show that
Ribo-0 cross-talks with the rpoS regulatory network and
accomplishes more complex gene regulation. With the
wild-type rpoS network, a cis-acting antisense element se-
questers the rpoS RBS and inhibits translation, whereas
the trans-acting DsrA binds to and opens the RNA
operator, relieving the repression. Now, the incorporation
of Ribo-0 reshapes this network as follows. On one hand,
when Ribo-0 is introduced into the network, DsrA turns
from an rpoS activator into an inhibitor; on the other,
DsrA is required for the optimal silencing effects of
Ribo-0. When both DsrA and Ribo-0 are present,
optimal repression of rpoS is achieved, forming a
NAND logic gate. By this means, the rpoS gene can be
activated and repressed by DsrA under different condi-
tions (i.e. with and without Ribo-0). In a broad sense,
the interplay between sRNAs demonstrated here may
also exist in other genetic networks and contribute to dif-
ferential gene expression in response to different
extracelllular signals or growth phases.
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